Premium
Clinical, histopathologic, and genetic features of pediatric primary myelofibrosis—An entity different from adults
Author(s) -
DeLario Melissa R.,
Sheehan Andrea M.,
Ataya Ramona,
Bertuch Alison A.,
Vega Carlos,
Webb C. Renee,
LopezTerrada Dolores,
Venkateswaran Lakshmi
Publication year - 2012
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.23140
Subject(s) - myelofibrosis , extramedullary hematopoiesis , medicine , hepatosplenomegaly , cytopenia , bone marrow , myeloproliferative neoplasm , pathology , disease , pediatrics , haematopoiesis , stem cell , biology , genetics
Primary myelofibrosis is a chronic myeloproliferative neoplasm characterized by cytopenias, leukoerythroblastosis, extramedullary hematopoiesis, hepatosplenomegaly and bone marrow fibrosis. Primary myelofibrosis is a rare disorder in adults; children are even less commonly affected by this entity, with the largest pediatric case series reporting on three patients. Most literature suggests spontaneous resolution of myelofibrosis without long term complications in the majority of affected children. We describe the clinical, pathologic, and molecular characteristics and outcomes of nineteen children with primary myelofibrosis treated in our center from 1984 to 2011. Most patients had cytopenia significant enough to require supportive therapy. No child developed malignant transformation and only five of the 19 children (26%) had spontaneous resolution of disease. Sequence analyses for JAK2 V617F and MPL W515L mutations were performed on bone marrow samples from 17 and six patients, respectively, and the results were negative. In conclusion, analysis of this large series of pediatric patients with primary myelofibrosis demonstrates distinct clinical, hematologic, bone marrow, and molecular features from adult patients.Am. J. Hematol. 87:461–464, 2012. © 2012 Wiley Periodicals, Inc.